RENX News and Press, RELX N.V. American Depositary Shares (Each representing One) From 11/25/20

NEW YORK, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today report...

NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today announ...

NEW YORK, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announces th...

NEW YORK, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, confirms tha...

NEW YORK, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announces it...

NEW YORK, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Renalytix AI, Inc. (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, a...

Most investors would agree on the fact that investing in high quality stocks can be a great strategy to maximize returns and keep risks under control over the long term. However, implementing such strategy is easier said than done. Like beauty, quality is in eye of the beholder to some degree,...

The following slide deck was published by RELX N.V. in conjunction with their 2018 Q2 earnings Read more ...

Amsterdam-based RELX N.V. (NYSE: RENX ) is up 0.4% in NYSE trading after an initiation at Buy by HSBC. More news on: RELX N.V., RELX PLC, Tech stocks news, Global news and forex, Read more ...

Strategic alliance to deliver practitioner-centred expertise to LexisNexis Risk Solutions clients while providing Temple Grange Partners with cutting-edge analytics capabilities LONDON and ATLANTA , May 30, 2018 /PRNewswire/ -- Temple Grange Partners, an innovative risk, regula...